Sangamo Biosciences, Inc. (SGMO) Reports Q4 Loss of $0.13
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
